News
Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...
Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...
18h
Investor's Business Daily on MSNBiohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...
Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential. On August 12, Leerink lowered ...
Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company’s potential treatment for a rare disease. The FDA’s Decision on BHVN’s Drug Candidate The FDA agreed to review BHVN ...
Investors in Biohaven Ltd (Symbol: BHVN) saw new options become available today, for the January 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...
Price Action: BHVN shares are up 1.28% at $49.74 on the last check Friday. Photo via Wikimedia Commons ...
Looking at the chart above, BHVN's low point in its 52 week range is $3.6933 per share, with $101 as the 52 week high point — that compares with a last trade of $18.45. Find out what 9 other ...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ' s sale to Pfizer Inc. for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of ...
BHVN Stock Soars on Pfizer Acquisition Today’s sale announcement comes as part of a larger news item: Biohaven’s fiscal first-quarter earnings. For the period, Biohaven reported $124 million ...
Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. (NYSE: BHVN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Biohaven Ltd. investors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results